title: Comparison of Treatment Goals for Moderate-to-Severe Psoriasis between Korean Dermatologists and the European Consensus Report.
abstract: BACKGROUND
  The development of therapies for psoriasis has led to the need for a new strategy to the treatment of patients with moderate-to-severe psoriasis. New consensus guidelines for psoriasis treatment have been developed in some countries, some of which have introduced treatment goals to determine the timing of therapeutic regimens for psoriasis.
  
  
  OBJECTIVE
  To investigate the opinions held by Korean dermatologists who specialize in psoriasis about treatment goals, and to compare these with the European consensus.
  
  
  METHODS
  Korean dermatologists who specialize in psoriasis were asked 11 questions about defining the treatment goals for psoriasis. The questionnaire included questions about the factors used to classify the severity of psoriasis, defining the induction and maintenance phases of psoriasis treatment, defining treatment responses during the induction phase, and defining treatment responses during the maintenance phase.
  
  
  RESULTS
  The Korean consensus showed responses that were almost similar to the European consensus, even without using the Delphi technique, which uses repeated rounds of questions to reach a consensus. Only one response that related to psoriasis severity in the context of the quality of patients' lives differed from the European consensus.
  
  
  CONCLUSIONS
  The concept of using treatment goals in the treatment of moderate-to-severe psoriasis can be applied to Korean psoriasis patients. Since a tool for assessing the quality of patients' lives is not commonly used in Korea, the development of a simple, rapidly completed, and region-specific health-related quality of life assessment tool would enable treatment goals to be used in routine clinical practice.
authors.affiliation: Department of Dermatology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.
authors.forename: Sang Woong
authors.initials: SW
authors.lastname: Youn
authors.affiliation: Department of Dermatology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.
authors.forename: Bo Ri
authors.initials: BR
authors.lastname: Kim
authors.affiliation: Department of Dermatology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
authors.forename: Joo Heung
authors.initials: JH
authors.lastname: Lee
authors.affiliation: Department of Dermatology, Korea University College of Medicine, Seoul, Korea.
authors.forename: Hae Jun
authors.initials: HJ
authors.lastname: Song
authors.affiliation: Department of Dermatology, Konkuk University School of Medicine, Seoul, Korea.
authors.forename: Yong Beom
authors.initials: YB
authors.lastname: Choe
authors.affiliation: Department of Dermatology, University of Ulsan College of Medicine, Seoul, Korea.
authors.forename: Ji Ho
authors.initials: JH
authors.lastname: Choi
authors.affiliation: Department of Dermatology, Kyung Hee University College of Medicine, Seoul, Korea.
authors.forename: Nack In
authors.initials: NI
authors.lastname: Kim
authors.affiliation: Department of Dermatology, Hallym University Sacred Heart Hospital, Anyang, Korea.
authors.forename: Kwang Joong
authors.initials: KJ
authors.lastname: Kim
authors.affiliation: Department of Dermatology, National Medical Center, Seoul, Korea.
authors.forename: Jai Il
authors.initials: JI
authors.lastname: Youn
keywords: Consensus; Psoriasis; Severity of illness index; Treatment goal
references.citation: Clin Exp Dermatol. 1994 May;19(3):210-6
references.pmid: 8033378
references.citation: J Dermatol. 2013 Sep;40(9):683-95
references.pmid: 24033880
references.citation: Ann Dermatol. 2010 Nov;22(4):389-96
references.pmid: 21165207
references.citation: Arch Dermatol Res. 2011 Jan;303(1):1-10
references.pmid: 20857129
references.citation: J Invest Dermatol. 2012 Oct;132(10):2464-5
references.pmid: 22592153
references.citation: Arch Dermatol. 2012 Jan;148(1):95-102
references.pmid: 22250239
references.citation: Acta Derm Venereol. 2014 Sep;94(5):547-52
references.pmid: 24549301
references.citation: Br J Dermatol. 2009 Nov;161(5):987-1019
references.pmid: 19857207
references.citation: Clin Dermatol. 2005 Sep-Oct;23(5):491-502
references.pmid: 16179183
references.citation: J Invest Dermatol. 2013 Feb;133(2):377-85
references.pmid: 23014338
references.citation: Ann Dermatol. 2013 May;25(2):156-62
references.pmid: 23717005
references.citation: N Engl J Med. 2009 Jul 30;361(5):496-509
references.pmid: 19641206
references.citation: Br J Dermatol. 2014 Nov;171(5):1091-8
references.pmid: 24861358
references.citation: J Eur Acad Dermatol Venereol. 2010 Dec;24(12):1458-67
references.pmid: 20456548